Simplex Trading’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $242K | Sell |
78,900
-199,400
| -72% | -$864K | ﹤0.01% | 4065 |
|
|
2025
Q4 | $991K | Buy |
278,300
+57,000
| +26% | +$349K | ﹤0.01% | 2615 |
|
|
2025
Q3 | $1.97M | Buy |
221,300
+53,300
| +32% | +$541K | ﹤0.01% | 2341 |
|
|
2025
Q2 | $1.55M | Sell |
168,000
-45,400
| -21% | -$388K | ﹤0.01% | 2343 |
|
|
2025
Q1 | $1.83M | Buy |
213,400
+49,100
| +30% | +$464K | ﹤0.01% | 2118 |
|
|
2024
Q4 | $1.76M | Buy |
164,300
+5,400
| +3% | +$41.5K | ﹤0.01% | 2308 |
|
|
2024
Q3 | $902K | Buy |
158,900
+65,500
| +70% | +$378K | ﹤0.01% | 3011 |
|
|
2024
Q2 | $394K | Sell |
93,400
-53,200
| -36% | -$215K | ﹤0.01% | 3908 |
|
|
2024
Q1 | $746K | Sell |
146,600
-85,000
| -37% | -$478K | ﹤0.01% | 3430 |
|
|
2023
Q4 | $2.16M | Buy |
231,600
+118,900
| +106% | +$819K | ﹤0.01% | 2294 |
|
|
2023
Q3 | $738K | Sell |
112,700
-38,400
| -25% | -$306K | ﹤0.01% | 2990 |
|
|
2023
Q2 | $1.23M | Buy |
151,100
+34,500
| +30% | +$296K | ﹤0.01% | 2408 |
|
|
2023
Q1 | $999K | Buy |
116,600
+35,400
| +44% | +$353K | ﹤0.01% | 2587 |
|
|
2022
Q4 | $751K | Sell |
81,200
-26,100
| -24% | -$279K | ﹤0.01% | 2751 |
|
|
2022
Q3 | $1.11M | Sell |
107,300
-6,800
| -6% | -$71.8K | ﹤0.01% | 2543 |
|
|
2022
Q2 | $1.14M | Sell |
114,100
-66,400
| -37% | -$629K | ﹤0.01% | 2471 |
|
|
2022
Q1 | $2.22M | Buy |
180,500
+126,500
| +234% | +$1.56M | ﹤0.01% | 2007 |
|
|
2021
Q4 | $936K | Sell |
54,000
-91,800
| -63% | -$1.74M | ﹤0.01% | 2952 |
|
|
2021
Q3 | $3.58M | Buy |
145,800
+5,200
| +4% | +$104K | ﹤0.01% | 1501 |
|
|
2021
Q2 | $3.21M | Buy |
+140,600
| New | +$2.08M | ﹤0.01% | 1600 |
|
|
2021
Q1 | – | Sell |
-22
| Closed | -$11K | – | 8768 |
|
|
2020
Q4 | $11K | Sell |
22
-166
| -88% | -$875 | ﹤0.01% | 7337 |
|
|
2020
Q3 | $85K | Buy |
+188
| New | +$809 | ﹤0.01% | 5066 |
|
|
2020
Q2 | – | Sell |
-148
| Closed | -$46K | – | 7572 |
|
|
2020
Q1 | $46K | Buy |
148
+140
| +1,750% | +$488 | ﹤0.01% | 5207 |
|
|
2019
Q4 | $2K | Sell |
8
-71
| -90% | -$186 | ﹤0.01% | 6945 |
|
|
2019
Q3 | $24K | Sell |
79
-56
| -41% | -$162 | ﹤0.01% | 5663 |
|
|
2019
Q2 | $45K | Buy |
135
+98
| +265% | +$304 | ﹤0.01% | 4941 |
|
|
2019
Q1 | $11K | Buy |
+37
| New | +$88 | ﹤0.01% | 6084 |
|
|
2018
Q3 | – | Sell |
-47
| Closed | -$12K | – | 7379 |
|
|
2018
Q2 | $12K | Buy |
+47
| New | +$131 | ﹤0.01% | 6209 |
|
|
2018
Q1 | – | Sell |
-89
| Closed | -$3K | – | 6102 |
|
|
2017
Q4 | $3K | Sell |
89
-52
| -37% | -$205 | ﹤0.01% | 4845 |
|
|
2017
Q3 | $5K | Sell |
141
-11
| -7% | -$49 | ﹤0.01% | 4342 |
|
|
2017
Q2 | $26K | Sell |
152
-166
| -52% | -$960 | ﹤0.01% | 3020 |
|
|
2017
Q1 | $48K | Sell |
318
-31
| -9% | -$160 | ﹤0.01% | 2407 |
|
|
2016
Q4 | $39K | Sell |
349
-83
| -19% | -$296 | ﹤0.01% | 2397 |
|
|
2016
Q3 | $43K | Sell |
432
-27
| -6% | -$114 | ﹤0.01% | 2223 |
|
|
2016
Q2 | $106K | Buy |
459
+314
| +217% | +$1.52K | 0.01% | 1429 |
|
|
2016
Q1 | $9K | Buy |
145
+32
| +28% | +$141 | ﹤0.01% | 3545 |
|
|
2015
Q4 | $13K | Buy |
+113
| New | +$804 | ﹤0.01% | 3057 |
|
Other funds holding AVXL
VCM
SF
VPM
Simplex Trading's AVXL Position: Q1 2026 in Review
Simplex Trading opened a new position in Anavex Life Sciences (AVXL) in Q1 2026: 47,867 shares worth $147K. The stake represents ﹤0.01% of the portfolio and ranks #4654 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AVXL as recently as Q1 2025.
Simplex Trading first reported a position in AVXL in Q1 2016 and has held it in 29 quarters since. The position peaked at $671K in Q4 2023. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.
- Simplex Trading held 47,867 shares of Anavex Life Sciences worth $147K as of Q1 2026.
- Anavex Life Sciences was a new Simplex Trading position in Q1 2026.
- Anavex Life Sciences made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #4654 holding.
- Simplex Trading first reported a position in Anavex Life Sciences in Q1 2016 and has held it in 29 quarters since.
- Simplex Trading's Anavex Life Sciences position peaked at $671K in Q4 2023.
- 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.